Invacare Corporation (IVC)
NYSE: IVC
· Real-Time Price · USD
0.66
-0.02 (-2.22%)
At close: Jan 31, 2023, 10:00 PM
Invacare Revenue Breakdown
Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
---|---|---|---|
All Other Revenue | 30.47M | 32.36M | 34.34M |
All Other Revenue Growth | -5.84% | -5.77% | n/a |
Revenue by Geography
Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
---|---|---|---|
All Other Revenue | 4.88M | 5.14M | 4.59M |
All Other Revenue Growth | -5.06% | +12.04% | n/a |
Europe (Emea) Revenue | 11.93M | 12.93M | 12.4M |
Europe (Emea) Revenue Growth | -7.70% | +4.23% | n/a |
North America (Na) Revenue | 1.38M | 711K | 831K |
North America (Na) Revenue Growth | +94.51% | -14.44% | n/a |
Operating Expense Breakdown
Period Ending | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 53.81M | 52.23M | 55.37M | 58.62M | 60.56M | 53.52M | 56.13M | 63.77M | 58.82M | 61.69M | 55.53M | 57.4M | 61.74M | 63.03M | 63.54M | 68.25M | 65.24M | 66.93M | 69.94M | 73.76M | 71.26M | 72.66M | 75.92M | 75.72M | 72.51M | 74.52M | 77.7M | 78.72M | 73.21M | 78.48M | 77.58M | 82.55M | 81.24M |
Selling, General, and Administrative Revenue Growth | +3.03% | -5.67% | -5.56% | -3.20% | +13.16% | -4.66% | -11.97% | +8.41% | -4.64% | +11.08% | -3.26% | -7.02% | -2.04% | -0.81% | -6.91% | +4.62% | -2.53% | -4.30% | -5.18% | +3.51% | -1.92% | -4.29% | +0.26% | +4.42% | -2.69% | -4.10% | -1.29% | +7.52% | -6.72% | +1.17% | -6.02% | +1.61% | n/a |
Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |